EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Effect of sodium–glucose cotransporter 2 inhibitors on serum low‐density lipoprotein cholesterol in Japanese patients with type 2 diabetes mellitus

Tasuku Imada, Naoto Katakami iD, Hirotaka Watanabe, Shuhei Nishina, Shugo Sasaki, Mitsuyoshi Takahara iD, Iichiro Shimomura, Tsunehiko Yamamoto

Journal of Diabetes Investigation · 2024

DOI: 10.1111/jdi.14179 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Diabetes Investigation, 2024. Verfasst von Tasuku Imada und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diabetes and Endocrinology, Kansai-Rosai Hospital, Amagasaki City, Hyogo, Japan. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Sodium-Glucose Transporter 2 Inhibitors, Cholesterol, LDL. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims/Introduction We aimed to evaluate factors that influence changes in blood low‐density lipoprotein cholesterol (LDL‐C) levels after treatment with sodium–glucose cotransporter 2 (SGLT2) inhibitors in Japanese patients with type 2 diabetes. Materials and Methods We retrospectively analyzed clinical data of outpatients newly initiated on SGLT2 inhibitors ( n = 176) and other oral antidiabetic drugs ( n = 227). The patients were classified into four subgroups according to statin administration and baseline LDL‐C levels (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Sodium-Glucose Transporter 2 InhibitorsCholesterol, LDLHumansMaleFemaleRetrospective StudiesMiddle AgedAgedJapanHypoglycemic AgentsHydroxymethylglutaryl-CoA Reductase InhibitorsFollow-Up StudiesBiomarkersBlood GlucoseEast Asian People

Stichwörter der Autor:innen

Low‐density lipoprotein cholesterolSodium–glucose cotransporter 2 inhibitorType 2 diabetes mellitus

Substanzen

Sodium-Glucose Transporter 2 InhibitorsCholesterol, LDLHypoglycemic AgentsHydroxymethylglutaryl-CoA Reductase InhibitorsBiomarkersBlood Glucose

Autor:innen und Institutionen

  • Department of Diabetes and Endocrinology, Kansai-Rosai Hospital, Amagasaki City, Hyogo, Japan.
  • Department of Metabolic Medicine, Osaka University Graduate School of Medicine, Suita City, Osaka, Japan.
  • Department of Diabetes Care Medicine, Osaka University Graduate School of Medicine, Suita City, Osaka, Japan.

ORCID-Profile: Naoto Katakami, Mitsuyoshi Takahara

Zitieren

APA

Imada, T., Katakami, N., Watanabe, H., Nishina, S., Sasaki, S., Takahara, M., Shimomura, I., & Yamamoto, T. (2024). Effect of sodium–glucose cotransporter 2 inhibitors on serum low‐density lipoprotein cholesterol in Japanese patients with type 2 diabetes mellitus. Journal of Diabetes Investigation. https://doi.org/10.1111/jdi.14179

Vancouver

Imada T, Katakami N, Watanabe H, Nishina S, Sasaki S, Takahara M, et al. Effect of sodium–glucose cotransporter 2 inhibitors on serum low‐density lipoprotein cholesterol in Japanese patients with type 2 diabetes mellitus. Journal of Diabetes Investigation. 2024. doi:10.1111/jdi.14179

BibTeX
@article{Imada2024,
  author = {Imada, Tasuku and Katakami, Naoto and Watanabe, Hirotaka and Nishina, Shuhei and Sasaki, Shugo and Takahara, Mitsuyoshi and Shimomura, Iichiro and Yamamoto, Tsunehiko},
  title = {Effect of sodium–glucose cotransporter 2 inhibitors on serum low‐density lipoprotein cholesterol in Japanese patients with type 2 diabetes mellitus},
  journal = {Journal of Diabetes Investigation},
  year = {2024},
  doi = {10.1111/jdi.14179}
}
Kostenlos starten →